ML is poised to become faster and more accessible by 2026. Simply having the support of GenAI already gives it an advantage over other AI-based solutions.
Objective Cardiovascular diseases (CVD) remain the leading cause of mortality globally, necessitating early risk identification to improve prevention and management strategies. Traditional risk ...